BMY Dividend Yield Compared to Other Stocks

BMY's dividend yield is significantly higher than the S&P 500 average.

This is because BMY's dividend payout ratio is around 50%, which is relatively high compared to other stocks.

Compared to other pharmaceutical stocks, BMY's dividend yield is around 10% higher than Johnson & Johnson's and 5% higher than Pfizer's.

This makes BMY an attractive option for income investors.

However, it's worth noting that BMY's dividend yield is lower than some other stocks in the industry, such as AbbVie, which has a dividend yield of around 4.5%.

This suggests that BMY's dividend payout may not be as sustainable in the long term.

Additional reading: Dividend Payout Ratio News

The dividend yield of Bristol-Myers Squibb Company (BMY) has fluctuated over the years, with the highest annual increase being 47.79% in 2023.

BMY's maximum annual dividend yield was 4.47% in 2023, a significant increase from the previous year.

Here are the yearly fluctuations in BMY's dividend yield:

Bristol-Myers Squibb Company's dividend yield is 4.42%, which means that for every $100 invested in the company's stock, investors would receive $4.42 in dividends per year.

The company's payout ratio is NaN%, indicating that NaN% of the company's earnings are paid out as dividends. This is a crucial metric to consider when evaluating a company's financial health.

BMY's annual dividend is $2.48 per share, which is the total amount of dividends paid out to shareholders in a year.

The ex-dividend date for Bristol-Myers Squibb Company is January 3, 2025, meaning that buyers purchasing shares on or after that date will not be eligible to receive the next dividend payment.

Bristol-Myers Squibb Company pays dividends on a quarterly basis, providing investors with regular income.

The company has increased its dividends for 18 consecutive years, a positive sign of its financial stability and ability to pay consistent dividends in the future.

Expand your knowledge: Ally Financial Dividend

BMY's dividend yield is 4.42%, which means that for every $100 invested in the company's stock, investors would receive $4.42 in dividends per year.

The company's payout ratio is NaN%, which indicates that NaN% of the company's earnings are paid out as dividends. A low payout ratio can be a sign of a strong financial position.

For more insights, see: Payout Ratio vs Dividend Yield

BMY pays dividends on a quarterly basis, providing investors with regular income. This consistency is a positive sign of the company's financial stability.

The ex-dividend date for BMY is January 3, 2025, meaning that buyers purchasing shares on or after that date will not be eligible to receive the next dividend payment.

Intriguing read: Stock Symbol for Bristol Myers Squibb

Bristol-Myers Squibb Company (BMY) has a long history of paying consistent dividends, with 18 consecutive years of dividend increases. This is a testament to the company's financial stability.

The company pays dividends on a quarterly basis, providing investors with regular income.

BMY's dividend yield is 4.42%, which means that for every $100 invested in the company's stock, investors would receive $4.42 in dividends per year. This is a relatively high dividend yield compared to other companies.

BMY's payout ratio is NaN%, which means that the company is not currently paying out a significant portion of its earnings as dividends. A low payout ratio can indicate that the company has a strong financial position and can invest in growth opportunities.

Here's a quick summary of BMY's dividend yield over the years:

BMY's dividend yield has fluctuated over the years, with the highest annual increase being 47.79% in 2023.

Bristol Myers Squibb has a history of consistently raising its dividend payout, a streak that dates back to 2009.

This commitment to increasing dividends has contributed to the company's reputation as a reliable payer.

The stock price has been under pressure, which has resulted in an unusually high 4.8% dividend yield.

This high yield makes the shares an attractive option for income investors seeking a steady return on their investment.

BMY's dividend yield is a strong selling point, with a forward dividend yield of 4.43%, placing it in the top 30% of the market. This is a significant advantage for investors seeking regular income.

The company has a history of consecutive dividend increases, with 16 years of uninterrupted growth. This is a testament to the company's financial stability and commitment to shareholders.

A 4.43% dividend yield is a relatively high return, especially when compared to other sectors. In the Health Care sector, BMY's yield is a standout feature.

Investors can expect an 8% price target upside from sell-side analysts, which is a promising sign for the company's future performance.

A different take: Omega Healthcare Stock Quote

Bristol-Myers Squibb Company's (BMY) dividend yield of 4.42% is lower than AbbVie Inc.'s 3.25%, Merck & Co., Inc.'s 3.70%, and Johnson & Johnson's 3.12%.

BMY's dividend yield is also lower than Pfizer Inc.'s 6.59% and Amgen Inc.'s 3.03%.

The percentile ranks table shows that BMY's dividend yield is higher than 75% of companies in its country.

Here's a comparison of BMY's dividend yield with its peers:

BMY's dividend yield is less than Gilead Sciences, Inc.'s 2.91% and Eli Lilly and Company's 0.60%.

BMY's Dividend Yield has seen significant changes over the past ten years, with the current yield at 4.32%, a 63.61% increase from the historical average of 2.64%.

The highest Dividend Yield for Bristol-Myers Squibb Company (BMY) was in the June 2024 quarter at 1.45%, while the lowest was in the June 2016 quarter at 0.52%.

BMY has demonstrated a strong track record of consecutive dividend increases, with 16 years of consistent payments.

BMY's dividend payments per share have averaged 4.76% over the past 12 months.

The company's dividend growth is evident in its 6.38% average over the past 36 months, demonstrating a steady increase in shareholder rewards.

BMY's dividend history over the past 60 months has averaged 7.57%, showing a consistent pattern of growth.

Its dividend payout policies have been influenced by factors such as profitability, cash flow, and financial stability.

BMY's dividend history over the past 120 months has averaged 5.26%, indicating some fluctuations in the company's ability to sustain dividend growth over the long term.

Add BMY to your watchlist to stay informed about any updates to its dividend history and growth.

Recommended read: History of Recessions after Inverted Yield Curve

Bristol-Myers Squibb Company (BMY) has a consistent quarterly payout history.

The company's payout amount has remained constant at $0.6200 since 2025.

BMY's payout frequency is quarterly, with pay dates ranging from October 30th to February 1st.

Here's a breakdown of the company's payout history:

BMY's payout type is regular, and the company's qualified dividend status has been consistent since 2025.

BMY's Dividend Yield has seen significant changes over the years, with a mean historical average of 2.64% over the last ten years.

The current Dividend Yield of 4.32% is a 63.61% increase compared to the historical average.

BMY's Dividend Yield has ranged from a low of 0.52% in the June 2016 quarter to a high of 1.45% in the June 2024 quarter.

This means that investors have seen varying levels of returns on their investment in BMY over the years.

Bristol-Myers Squibb's dividend yield has fluctuated significantly over the years, with a maximum annual increase of 47.79% in 2023.

In 2023, the dividend yield reached a maximum of 4.47%, a substantial increase from the previous year.

The company's dividend yield has been as high as 4.47% in 2023 and as low as 0% in 2024.

The largest drop in dividend yield was a 100% decrease from 2023 to 2024.

Here's a breakdown of the dividend yield changes over the years:

Bristol-Myers Squibb Company (BMY) pays out a regular quarterly dividend of $0.6200 per share, with a qualified dividend status.

The payout amount has remained consistent since 2025, with the first payout in 2025-08-01 and subsequent payouts on the same date every quarter.

BMY's dividend yield has fluctuated over the years, with a maximum annual increase of 47.79% in 2023 and a maximum annual dividend yield of 4.47% in 2023.

Here's a breakdown of BMY's dividend yield by year:

BMY has a remarkable 16 years of consecutive dividend increase, a testament to its commitment to shareholder value.

The forward dividend yield of 4.43% puts BMY in the top 30% of its peers, making it an attractive option for income investors.

This strong yield is paired with an 8% price target upside from sell-side analysts, suggesting potential growth opportunities.

With its blend of low volatility and yield, BMY is an intriguing choice for those seeking a stable investment with a decent return.

Building a custom stock screener is a game-changer for investors. It allows you to compare thousands of companies, including Bristol-Myers Squibb Company, using the financials and key metrics that matter to you in a single view.

You can set up a custom screener using the Wisesheets add-on in Excel or Google Sheets. This will enable you to track specific metrics like the 3-year average Dividend Yield for Bristol-Myers Squibb Company (BMY).

To get started, you'll want to set up your spreadsheet with specific questions like "What is the 3-year average Dividend Yield for Bristol-Myers Squibb Company (BMY)?" and "What is the 5-year average Dividend Yield for Bristol-Myers Squibb Company (BMY)?"

By comparing the current Dividend Yield for Bristol-Myers Squibb Company (BMY) to its historical average, you can gain valuable insights into its investment potential.

A unique perspective: 3 Dividend Stocks to Buy and Hold Forever

BMY stock has a strong dividend history with 16 years of consecutive dividend increase. This is a testament to the company's financial stability and commitment to rewarding shareholders.

With a forward dividend yield of 4.43%, BMY is among the top 30% of dividend-paying stocks. This yield is attractive for income-seeking investors.

Sell-side analysts are optimistic about BMY's future performance, with an 8% price target upside that puts it in the middle 20% of their predictions. This suggests that the stock has room for growth.

BMY has a consistent dividend payout history, with a payout ratio of around 50% over the past few years.

The company has been increasing its dividend payments annually, with a 5-year CAGR of 10%.

BMY's dividend yield is around 4%, which is relatively high compared to other pharmaceutical companies.

The company's dividend payout is largely driven by its stable cash flows from established products.

BMY's strong cash flows from operations have enabled it to maintain a healthy dividend payout ratio.

The company's dividend yield is attractive to income investors, particularly those seeking relatively stable returns.

BMY's dividend payout strategy is focused on providing a stable return to shareholders, while also allowing for reinvestment in research and development.

Suggestion: Dividend Payout Ratio

Bmy's dividend yield is a crucial factor to consider for investors. It's calculated by dividing the annual dividend payment per share by the stock's current price.

A dividend yield of 4% means that for every $100 you invest, you'll receive $4 in dividend payments each year. This can be a significant source of passive income.

Historically, Bmy's dividend yield has ranged from 2% to 6% over the past decade. This indicates that the company has a relatively stable dividend policy.

Investors should be aware that a high dividend yield can sometimes be a sign of a struggling company. If the company's dividend yield is significantly higher than its peers, it may be a red flag.

However, in Bmy's case, the company's strong financials and history of consistent dividend payments make it a more attractive option.

Additional reading: National Health Investors Stock Dividend